Henlius Wins Chinese Approval For Rituximab RA Indication
Wider Potential Patient Population Allows Firm ‘Differentiated Strategy’
• By David Wallace
China’s NMPA has approved the Rituxan rival’s RA indication • Source: Micha Klootwijk / Alamy Stock Photo 
